(Q50535050)

English

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa

scientific article published on December 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantation incorporating carboplatin, cyclophosphamide and thiotepa (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

Feasibility and toxicity study of a high-dose chemotherapy regimen for autotransplantion incorporating carboplatin, cyclophosphamide and thiotepa (English)

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

1 reference

based on heuristic

inferred from title

autotransplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

author name string

S. Rodenhuis

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

J. W. Baars

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

J. H. Schornagel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

L. T. Vlasveld

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

I. Mandjes

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

H. M. Pinedo

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

D. J. Richel

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1286049

9 September 2022

publication date

1 December 1992

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

full work available at URL

http://annonc.oxfordjournals.org/cgi/content/abstract/3/10/855

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

9 September 2022

https://doi.org/10.1093/oxfordjournals.annonc.a058111

online access status

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1286049

23 November 2023

https://api.elsevier.com/content/article/PII:S0923753419654219?httpAccept=text/xml

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

https://api.elsevier.com/content/article/PII:S0923753419654219?httpAccept=text/plain

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

http://academic.oup.com/annonc/article-pdf/3/10/855/303648/3-10-855.pdf

Portable Document Format

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Annals of Oncology

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

10

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

855-860

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

Bone marrow autotransplantation

1

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Autologous bone marrow transplantation for patients with poor-prognosis lymphoma

3

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease

4

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

5

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

6

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Bone marrow autotransplantation for solid tumors--prospects

7

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients

8

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

9

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Feasibility study of high-dose carboplatin and etoposide in the salvage treatment of testicular cancer

10

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study

11

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

12

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

13

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin

15

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Carboplatin: an active drug in metastatic breast cancer.

16

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

18

1 reference

10.1093/OXFORDJOURNALS.ANNONC.A058111

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058111

23 November 2023

Identifiers

10.1093/OXFORDJOURNALS.ANNONC.A058111

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/1286049

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50535050&oldid=2016571193"